Moneycontrol PRO

Solara Active: Build-up of CRAMS pipeline to help rerate

Solara is looking at utilising cash flows to build a project pipeline for CRAMS, capitalising on inorganic opportunities

June 30, 2021 / 09:18 AM IST
Solara Active: Build-up of CRAMS pipeline to help rerate

Medicines (Representational image)

PRO Only Highlights
Quarterly performance largely backed by improved realisations
Medium-term triggers China plus and protectionist measures for tyre industry
Valuations not inexpensive; but improved medium-term outlook

The March 2021 quarter result from Solara Active Pharma Sciences (CMP: Rs 1,694; Market Cap: Rs 6,069 crore) showed a sharp ramp-up in the new Vizag facility. It also indicates that Phase II expansion into niche APIs (Active Pharmaceutical Ingredients) should come in handy to meet increased product inquiries, wherein clients are looking for diversification of supply chain, away from China. In addition, the recent acquisition of Aurore Life Science strengthens the company’s APIs and CRAMS (Contract Research and Manufacturing Services)...

  • PRO Panorama

    Moneycontrol Pro Panorama | Rate hike looming, heat is on retail investors

    May 26, 2022 / 06:26 PM IST

    In today’s edition of Moneycontrol Pro Panorama: A midcap in spotlight, warning for stock market, Modi’s three Ts in Tokyo, Start-Up Street and more

    Read Now
  • PRO Weekender

    Moneycontrol Pro Weekender | People’s Bank of China rides to the rescue 

    May 21, 2022 / 10:10 AM IST

    The central bank of China – an outlier in these times of quantitative tightening – has eased its policy to salvage the Chinese economy. And the messaging is not lost on global growth

    Read Now

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers